✦ LIBER ✦

Monitoring of acute myeloid leukemia by flow cytometry

✍ Scribed by Wolfgang Kern; Susanne Schnittger

Book ID: 107546214
Publisher: Current Science Inc.
Year: 2003
Tongue: English
Weight: 616 KB
Volume: 5
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-003-0027-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of terminal transferase in acu

Detection of terminal transferase in acute myeloid leukemia by flow cytometry

✍ Elisabeth Paietta; Bernadette Meenan; Claire Heavey; Dylan Thomas 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Flow cytometry CD45 gating for immunophe

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

✍ Lacombe, F; Durrieu, F; Briais, A; Dumain, P; Belloc, F; Bascans, E; Reiffers, J 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 231 KB

Acute myeloid leukemia with 11q23 transl

Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry

✍ Baer, M R; Stewart, C C; Lawrence, D; Arthur, D C; Mrózek, K; Strout, M P; Davey 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Flow cytometry in acute leukemia

✍ Renu Saxena; Hema Anand 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 451 KB

Detection of myeloperoxidase by flow cyt

Detection of myeloperoxidase by flow cytometry in acute leukemia

✍ Kazunori Nakase; Mary Sartor; Kenneth Bradstock 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

The value of flow cytometric detection of myeloperoxidase (MPO) in the differential diagnosis of acute leukemia was evaluated in 57 cases of acute leukemia and in 9 leukemia cell lines. Cells were fixed and permeabilized with Fix & Perm cell permeabilization kit at room temperature for 15 min each,

Monitoring of minimal residual disease i

Monitoring of minimal residual disease in acute myeloid leukemia

✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo